As an ideal follow-up to the FDA’s brain metastases workshop, the Society for Neuro-Oncology (SNO) will hold its first conference on brain metastases in August 2019.
“I believe there is significant room for collaboration between the focused ultrasound community and SNO,” said Suzanne LeBlang, MD, the Foundation’s Director of Clinical Relationships. “I could also envision an opportunity to cosponsor and support research and workshops.”
This meeting will provide an opportunity to increase awareness and share work in the field of focused ultrasound with others in the metastatic brain cancer community. Abstracts are due April 29. See submission information below.
CALL FOR ABSTRACTS
SNO Inaugural Conference on Brain Metastases
August 16 – 17, 2019
InterContinental Barclay Hotel
New York, NY
The inaugural SNO conference is for researchers and clinicians with a professional interest in metastatic brain tumors. This event will offer outstanding keynote and plenary addresses on a range of timely topics on this complex and increasingly important area of cancer medicine.
Abstracts are being solicited on a wide range of topics to include basic and translational research, as well as clinical practice, including radiation therapy, surgery, chemotherapy, targeted therapy/immunotherapy, multimodality therapy and clinical trials.
The abstract submission deadline is Monday, April 29, 11:59pm CST.
To submit your abstract and for conference information, click here.